Two Sigma Advisers
SLXP

Two Sigma Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Two Sigma Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,265
Closed -$649K – 2918
2014
Q2 		$649K Sell
5,265
-95,500
-95% -$10.6M 0.01% 1474
2014
Q1 		$10.4M Buy
+100,765
New +$10.3M 0.09% 237
2013
Q4 		– Sell
-44,065
Closed -$2.95M – 2648
2013
Q3 		$2.95M Sell
44,065
-195,700
-82% -$13.5M 0.04% 474
2013
Q2 		$15.9M Buy
+239,765
New +$13.7M 0.23% 91

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Two Sigma Advisers's SLXP Position: Q3 2014 in Review

Two Sigma Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014, closing a stake of 5,265 shares — an estimated $649K sold.

Two Sigma Advisers first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $15.9M in Q2 2013. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

  • Two Sigma Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q3 2014 after selling out during the quarter.
  • Two Sigma Advisers sold 5,265 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $649K.
  • Two Sigma Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
  • Two Sigma Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $15.9M in Q2 2013.
  • 348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on Two Sigma Advisers's 13F filing for Q3 2014, filed 14 Nov 2014.